Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Biokin Pharmaceutical and Cryoport announced Cryoport's temperature-controlled solutions will support Biokin Pharma's pending Phase I and II clinical trials in immuno-oncology in both the U.S. and China.
read more
Selvita announced it plans to separate into two companies.
read more
A critical focus for the FDA is preventing and mitigating potential medical product shortages.
read more
OcellO has entered an agreement to provide in vitro research services to Merus, a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics.
read more
Actinium has successfully completed the second module of its previously announced research and option agreement with Astellas Pharma and the third module has been initiated.
read more
Merck announced an investment of €150 million in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines.
read more
Transcenta announced its subsidiary has signed an exclusive agreement with Lilly to license a portfolio of novel biotherapeutics programs for development and commercialization in China.
read more
Thermo Fisher Scientific and Brammer Bio announced they have entered into a definitive agreement under which Thermo Fisher will acquire Brammer Bio for approximately $1.7 billion in cash.
read more
Veeva Systems announced Tom Schwenger will join the company as president and COO in September 2019 to lead strategy, sales, and services.
read more
Puma and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and commercialize NERLYNX® (neratinib) within Europe and part of Africa.
read more
Abzena has appointed Dr. Campbell Bunce as Chief Scientific Officer (CSO) and Bo Adair MBA as Senior Vice President Process and Operations.
read more
3P Biopharmaceuticals has signed a collaboration agreement with the Dutch biotech company Xenikos that will cover the global manufacturing of Xenikos’ proprietary lead product candidate T-Guard®.
read more
BioProcess Technology Consultants (BPTC) announced the closing of its acquisition by BDO USA, a professional services organization.
read more
The FDA posted warning letters to four companies who produce homeopathic drug products for significant violations of CGMP.
read more
Particle Testing Authority (PTA) announced the opening of its European laboratory in Munich, Germany.
read more